Recanalization rate in patients with proximal vein thrombosis treated with the direct oral anticoagulants.
暂无分享,去创建一个
W. Ageno | P. Prandoni | M. Di Nisio | N. Zanatta | D. Imberti | N. Mumoli | G. Camporese | S. Cuppini | R. Cappelli | R. Parisi | F. Noventa | L. Sarolo | G. Avruscio | M. Ciammaichella | E. Bucherini | L. Simioni | Giacomo Turatti | A. Visonà
[1] M. Prins,et al. Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism , 2017, The New England journal of medicine.
[2] P. Prandoni,et al. Inter-observer variability of compression ultrasound for the assessment of residual vein thrombosis. , 2016, Thrombosis research.
[3] M. Prins,et al. Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis , 2016, Thrombosis and Haemostasis.
[4] M. Prins,et al. Post-thrombotic syndrome and the risk of subsequent recurrent thromboembolism. , 2016, Thrombosis research.
[5] M. Prins,et al. The Impact of Residual Thrombosis on the Long-Term Outcome of Patients with Deep Venous Thrombosis Treated with Conventional Anticoagulation , 2015, Seminars in Thrombosis & Hemostasis.
[6] M. Prins,et al. Residual vein thrombosis and the risk of subsequent serious complications. , 2015, Thrombosis research.
[7] G. Raskob,et al. Thrombosis: a major contributor to global disease burden. , 2014, Thrombosis research.
[8] G. Raskob,et al. Thrombosis: A major contributor to global disease burden , 2014, Thrombosis and Haemostasis.
[9] J. Douketis,et al. Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis , 2013, Thrombosis and Haemostasis.
[10] P. Prandoni,et al. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism , 2013, Thrombosis and Haemostasis.
[11] R. Hull,et al. Long-term low-molecular-weight heparin and the post-thrombotic syndrome: a systematic review. , 2011, The American journal of medicine.
[12] P. Wells,et al. Systematic Review: Case-Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding Events Among Patients Treated for Venous Thromboembolism , 2010, Annals of Internal Medicine.
[13] M. Prins,et al. Quality of oral anticoagulant treatment and risk of subsequent recurrent thromboembolism in patients with deep vein thrombosis , 2007, Journal of thrombosis and haemostasis : JTH.
[14] Paolo Prandoni,et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. , 2007, Haematologica.
[15] A. Forster,et al. Effect of study setting on anticoagulation control: a systematic review and metaregression. , 2006, Chest.
[16] M. Prins,et al. Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome , 2005, Journal of thrombosis and haemostasis : JTH.
[17] T. Baglin,et al. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study , 2003, The Lancet.
[18] M Gent,et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. , 1999, The New England journal of medicine.
[19] Paolo Prandoni,et al. The Long-Term Clinical Course of Acute Deep Venous Thrombosis , 1996, Annals of Internal Medicine.
[20] Olle Linder,et al. A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism , 1995 .
[21] K. Schulman,et al. Cost-effectiveness analyses. , 1995, The New England journal of medicine.
[22] S. Schulman,et al. A Comparison of Six Weeks With Six Months of Oral Anticoagulant Therapy After a First Episode of Venous Thromboembolism , 1996 .
[23] P Prandoni,et al. A Simple Ultrasound Approach for Detection of Recurrent Proximal‐Vein Thrombosis , 1993, Circulation.